$ Value
$0
Shares
54,240
Price
$0
Filed
Feb 9
Insider
Name
Foff Erin Pennock
Title
Chief Medical Officer
CIK
0002021233
Roles
Transaction Details
Transaction Date
2026-02-05
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
54,240
Footnotes
Represents a restricted stock unit ("RSU") award. 1/4th of the RSUs shall vest on January 1, 2027, and 1/16th of the RSUs shall vest on each subsequent April 1, July 1, October 1 and January 1 thereafter, subject to the Reporting Person's continued service through each vesting date. | Each RSU represents a contingent right to receive one share of voting common stock of the Issuer. | 1/4th of the total shares underlying the option shall vest on February 5, 2027, and 1/48th of the total shares shall vest each month thereafter on the same day of the month, subject to the Reporting Person's continued service through each vesting date.
Filing Info
Foff Erin Pennock's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-16 | MPLT | ▼ | $8K |
| 2026-04-16 | MPLT | ▼ | $24K |
| 2026-04-15 | MPLT | ▼ | $55K |
| 2026-02-05 | MPLT | A | $0 |
| 2026-02-05 | MPLT | A | $0 |
| 2026-01-27 | MPLT | F | $802K |
| 2025-10-27 | MPLT | A | $0 |
| 2025-10-27 | MPLT | A | $0 |
Other Insiders at MPLT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Pavlov George | $441K | — | 2026-02-20 |
| Garnett Timothy John | $253K | — | 2026-02-10 |
|
Kroeger Christopher A.
Chief Executive Officer
|
— | $521K | 2026-04-16 |
|
GILLIS JONATHAN
CAAO and PAO
|
— | $96K | 2026-04-15 |
|
Lillie James Woodruff
Chief Scientific Officer
|
— | $123K | 2026-04-16 |
|
Hanson Kristopher
General Counsel
|
— | $49K | 2026-04-16 |
| Malenka Robert C. | — | $1.6M | 2026-04-15 |
|
Foff Erin Pennock
Chief Medical Officer
|
— | $87K | 2026-04-16 |
|
Kreitzer Anatol
Chief Discovery Officer
|
— | $88K | 2026-04-15 |
|
Setia Vishwas
Chief Financial Officer
|
— | $79K | 2026-04-16 |